Dr. Pangborn is the founder of Pangborn Associates, LLC, which advises pre-IPO companies in the chemical, materials, and energy industries. Past and current clients include Diversa, Materia, CSP Technologies, Metabolix and Genomatica. Dr. Pangborn has also served as a senior advisor to Cargill’s Industrial BioProducts Division, and played a key role in helping to develop and implement strategy for this key corporate growth initiative. Previously Dr. Pangborn was employed at Dow Chemical in a variety of R&D and business leadership roles, rising to the post of Vice President of Central Research and Development. He holds a Ph.D. in physics from Dartmouth, attended Harvard Business School, and was an officer in the U.S. Marine Corps.